It is also known that some of these mutations (in BRAF, NRAS and TERT) are found both in benign lesions and in melanomas, whereas those in CDKN2A, TP53 and phosphatase and tensin homolog (PTEN) are only observed in invasive melanomas [8]. The gene discussed is NRAS; the disease is melanoma.